4Njuangang S, Liyanage C, Akintoye A. Key performance meas- ures to control maintenance- associated HAIs ]-Jl. INT J Health Care Qual Assur, 2015,28 (7) : 690- 708.
6Hughes C,Tunney M, Bradley MC. Infection control strategies for preventing the transmission of meticillin- resistant Staphy- lococcus aureus (MRSA) in nursing homes for older people (Review) EJ. Cochrane Database of Systematic Reviews,2013 (11),1-26.
10Hale R,Powell T, Drey NS, et al. Working practices and suc- cess of infection prevention and control teams[-J. Journal of Hospital Infection,2015,89(2) 77 81.
6Foss M,Bernard H. Enhanced recovery after surgery: implica tions for nurses[J]. Br J Nuts, 2012,2I (4) : 221 - 223.
7Isturiz R. Global resistance trends and the potential impact on empirical therapy[J]. Int J Antimicrob Agent, 2008,32(S4):S201-S206.
8Lee S Y, Kotapati S, Kuti J L, et al. Impact of extendedspectrum betalactamase producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study[J]. Infect Control Hosp Epidemiol, 2006,27(11):1226- 1232.
9Cosgrove S E,Qi Y L,Kaye K S,et al. The impact of methicillinresistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges[J]. Infect Control Hosp Epidemiol,2005,26(2):166-174.
10Cosgrove S E, Sakoulas G, Perencevich E N, et al. Comparison of mortality associated with methicillinresistant and methicillinsusceptible Staphylococcus aureus bacteremia :a metaanalysis[J]Clin Infect Dis,2003,36(1):53-59.
